About NeuroLambda Therapeutics
NeuroLambda Therapeutics is a private company based in Cambridge, Massachusetts, incorporated in 2023 in Delaware. It has reported $3,000,000 raised in one offering on Form D since July 2024.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 21, 2024 | Jul 17, 2024 | $3,000,000of $5.0M target | 1 | $3.0M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on NeuroLambda Therapeutics's Form D filed Jul 17, 2024.